Literature DB >> 17614198

Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.

Carolina Perez-Pastene1, Stephanie A Cobb, Fernando Díaz-Grez, Mary M Hulihan, Marcelo Miranda, Pablo Venegas, Osvaldo Trujillo Godoy, Jennifer M Kachergus, Owen A Ross, Luis Layson, Matthew J Farrer, Juan Segura-Aguilar.   

Abstract

Pathogenic substitutions in the leucine-rich repeat kinase 2 protein (Lrrk2), R1441G and G2019S, are a prevalent cause of autosomal dominant and sporadic Parkinson's disease in the Northern Spanish population. In this study we examined the frequency of these two substitutions in 166 Parkinson's disease patients and 153 controls from Chile, a population with Spanish/European-Amerindian admixture. Lrrk2 R1441G was not observed, however Lrrk2 G2019S was detected in one familial and four sporadic Parkinson's disease patients. These findings suggest Lrrk2 G2019S may play an important role in Parkinson's disease on the South American Continent and further studies are now warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17614198      PMCID: PMC1986707          DOI: 10.1016/j.neulet.2007.06.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  23 in total

1.  Frequency of the hypervariable DNA loci D18S849, D3S1744, D12S1090 and D1S80 in a mixed ancestry population of Chilean blood donors.

Authors:  M Acuña; H Jorquera; L Cifuentes; L Armanet
Journal:  Genet Mol Res       Date:  2002-06-30

2.  Lrrk2-associated parkinsonism is a major cause of disease in Northern Spain.

Authors:  María C González-Fernández; Elena Lezcano; Owen A Ross; Juan C Gómez-Esteban; Fernando Gómez-Busto; Fernando Velasco; Maite Alvarez-Alvarez; María B Rodríguez-Martínez; Roberto Ciordia; Juan J Zarranz; Matthew J Farrer; Ignacio F Mata; Marian M de Pancorbo
Journal:  Parkinsonism Relat Disord       Date:  2007-05-30       Impact factor: 4.891

3.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

4.  G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort.

Authors:  Jose Miguel Bras; Rita Joao Guerreiro; Maria Helena Ribeiro; Cristina Januario; Ana Morgadinho; Catarina Resende Oliveira; Luis Cunha; John Hardy; Andrew Singleton
Journal:  Mov Disord       Date:  2005-12       Impact factor: 10.338

5.  The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

Authors:  E K Tan; H Shen; L C S Tan; M Farrer; K Yew; E Chua; R D Jamora; K Puvan; K Y Puong; Y Zhao; R Pavanni; M C Wong; Yuen Yih; L Skipper; Jian-Jun Liu
Journal:  Neurosci Lett       Date:  2005-08-26       Impact factor: 3.046

6.  LRRK2 R1441G in Spanish patients with Parkinson's disease.

Authors:  Ignacio F Mata; Julie P Taylor; Jennifer Kachergus; Mary Hulihan; Cecilia Huerta; Carlos Lahoz; Marta Blazquez; Luis M Guisasola; Carlos Salvador; Renee Ribacoba; Carmen Martinez; Matthew Farrer; Victoria Alvarez
Journal:  Neurosci Lett       Date:  2005-04-13       Impact factor: 3.046

7.  A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.

Authors:  L Warren; R Gibson; L Ishihara; R Elango; Z Xue; A Akkari; L Ragone; Rajesh Pahwa; Joseph Jankovic; Martha Nance; Alan Freeman; Ray L Watts; F Hentati
Journal:  Parkinsonism Relat Disord       Date:  2007-04-11       Impact factor: 4.891

8.  Clinical features of LRRK2-associated Parkinson's disease in central Norway.

Authors:  Jan O Aasly; Mathias Toft; Ignacio Fernandez-Mata; Jennifer Kachergus; Mary Hulihan; Linda R White; Matthew Farrer
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

9.  Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.

Authors:  Tiziana Squillaro; Franca Cambi; Giuseppe Ciacci; Simone Rossi; Monica Ulivelli; Alessandro Malandrini; Maria Antonietta Mencarelli; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  J Hum Genet       Date:  2007-01-18       Impact factor: 3.172

Review 10.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01
View more
  6 in total

1.  Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.

Authors:  Ignacio F Mata; Greggory J Wilhoite; Dora Yearout; Justin A Bacon; Mario Cornejo-Olivas; Pilar Mazzetti; Victoria Marca; Olimpio Ortega; Oscar Acosta; Carlos Cosentino; Luis Torres; Angel C Medina; Carolina Perez-Pastene; Fernando Díaz-Grez; Carles Vilariño-Güell; Pablo Venegas; Marcelo Miranda; Osvaldo Trujillo-Godoy; Luis Layson; Rodrigo Avello; Elena Dieguez; Victor Raggio; Federico Micheli; Claudia Perandones; Victoria Alvarez; Juan Segura-Aguilar; Matthew J Farrer; Cyrus P Zabetian; Owen A Ross
Journal:  Parkinsonism Relat Disord       Date:  2011-05-31       Impact factor: 4.891

Review 2.  The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.

Authors:  Avner Thaler; Elissa Ash; Ziv Gan-Or; Avi Orr-Urtreger; Nir Giladi
Journal:  J Neural Transm (Vienna)       Date:  2009-11       Impact factor: 3.575

3.  Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.

Authors:  Andrés Felipe Duque; Juan Carlos Lopez; Bruno Benitez; Helena Hernandez; Juan José Yunis; William Fernandez; Humberto Arboleda; Gonzalo Arboleda
Journal:  Colomb Med (Cali)       Date:  2015-09-30

4.  Commentary to medical genetics and genomic medicine in Chile: Chilean experience on molecular diagnosis for neurodegenerative disorders.

Authors:  Marcelo Miranda; María Leonor Bustamante
Journal:  Mol Genet Genomic Med       Date:  2017-05-02       Impact factor: 2.183

5.  Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Authors:  Mario Cornejo-Olivas; Luis Torres; Mario R Velit-Salazar; Miguel Inca-Martinez; Pilar Mazzetti; Carlos Cosentino; Federico Micheli; Claudia Perandones; Elena Dieguez; Victor Raggio; Vitor Tumas; Vanderci Borges; Henrique B Ferraz; Carlos R M Rieder; Artur Shumacher-Schuh; Carlos Velez-Pardo; Marlene Jimenez-Del-Rio; Francisco Lopera; Jorge Chang-Castello; Brennie Andreé-Munoz; Sarah Waldherr; Dora Yearout; Cyrus P Zabetian; Ignacio F Mata
Journal:  NPJ Parkinsons Dis       Date:  2017-06-02

Review 6.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.